Clinical Trials Logo

Clinical Trial Summary

This study aims to compare the effects of 6-week vibration and non-vibration foam rolling on neuromuscular control and performance in male soccer players.


Clinical Trial Description

The typical warm-up protocol consists of different stretching exercises, sub-maximal aerobic activities, and sports-related activities. However, in recent years, warm-up protocols involving different methods have been applied and recommended. Foam rolling (FR) via foam roller, one of these methods, has become a common and popular method in many sports settings. While the popularity and use of the foam rolling method is gradually increasing, in recent years this method has begun to be applied as vibration and included in warming protocols. The aim of this study is to compare the effects of 6-week vibration and non-vibration foam rolling on neuromuscular control and performance in male soccer players. Within the scope of initial assessments; knee flexor and extensor muscle strength and Hamstring/Quadriceps muscle strength ratio with the Lafayette manual muscle testing device, flexibility with the sit-and-reach test, dynamic balance with the Y balance test, reaction time with the "Test You Brain Pro System", lower extremity anaerobic power with the Wingate anaerobic power test, agility with the t-test and sprint with the 20-m sprint test will be evaluated. After the initial assessment, vibration and non-vibration foam rolling methods will be applied to the gluteal, tensor fascia latae, hamstring, quadriceps femoris and gastrocnemius muscles of both lower extremities of the participants in the intervention groups, in addition to the routine warm-up protocol, 3 days a week for a total of 15 minutes a day for 6 weeks. No intervention will be applied to the participants in the control group. This group will continue the routine warm-up protocol. After the methods applied to the intervention groups for 6 weeks, the initial assessments applied to all participants will be repeated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05988268
Study type Interventional
Source Celal Bayar University
Contact
Status Completed
Phase N/A
Start date August 7, 2023
Completion date October 2, 2023

See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1